Home / Omalizumab / Italy
IT ATC R03DX05 · updated 2 Nov 2026
Omalizumab shortage in Italy
Is there an Omalizumab shortage in Italy?
Yes. As of 2 Nov 2026, 2 Omalizumab products are reported short in Italy. No return date has been given. Main reason: increased demand.
Also short in Canada, Spain, Austria. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | OMLYCLO anticipated | CELLTRION HEALTHCARE HUNGARY KFT | 8 Dec 2026 | not given | Increased demand Elevata richiesta |
| IT | OMLYCLO anticipated | CELLTRION HEALTHCARE HUNGARY KFT | 8 Dec 2026 | not given | Increased demand Elevata richiesta |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.